SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 260 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $105,000 | +1650.0% | 1,403 | +601.5% | 0.00% | – |
| Q1 2020 | $6,000 | -93.9% | 200 | -85.3% | 0.00% | -100.0% |
| Q4 2019 | $98,000 | -41.0% | 1,363 | +17.2% | 0.00% | -50.0% |
| Q3 2019 | $166,000 | -18.6% | 1,163 | +4.4% | 0.01% | -33.3% |
| Q2 2019 | $204,000 | -81.1% | 1,114 | -83.6% | 0.01% | -81.6% |
| Q1 2019 | $1,079,000 | +639.0% | 6,787 | +346.8% | 0.05% | +716.7% |
| Q4 2018 | $146,000 | -33.3% | 1,519 | -2.0% | 0.01% | -50.0% |
| Q3 2018 | $219,000 | -9.9% | 1,550 | 0.0% | 0.01% | -40.0% |
| Q2 2018 | $243,000 | -2.8% | 1,550 | 0.0% | 0.02% | -39.4% |
| Q1 2018 | $250,000 | – | 1,550 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |